Essential medicines are still essential

被引:25
作者
Gray, Andy L. [1 ,2 ]
Wirtz, Veronika J. [1 ,3 ]
M'tHoen, Ellen F. [1 ,5 ]
Reich, Michael R. [1 ,4 ]
Hogerzeil, Hans V. [1 ,5 ]
机构
[1] Lancet Commiss Essential Med Policies, Mexico City, DF, Mexico
[2] Univ KwaZulu Natal, Sch Hlth Sci, Durban, South Africa
[3] Boston Univ, Sch Publ Hlth, Boston, MA USA
[4] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA
[5] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
关键词
D O I
10.1016/S0140-6736(15)00514-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1601 / 1603
页数:3
相关论文
共 14 条
[1]  
[Anonymous], 2014, LANCET, V384, P1642, DOI 10.1016/S0140-6736(14)62017-1
[2]  
[Anonymous], 2015, NY Times
[3]  
[Anonymous], PAT SIT KEY PROD TRE
[4]   The concept of essential medicines: lessons for rich countries [J].
Hogerzeil, HV .
BRITISH MEDICAL JOURNAL, 2004, 329 (7475) :1169-1172
[5]   Are we moving towards a new definition of essential medicines [J].
Manikandan, S. .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (03) :123-125
[6]   Evaluating the quality and use of economic data in decisions about essential medicines [J].
Moucheraud, Corrina ;
Wirtz, Veronika J. ;
Reich, Michael R. .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2015, 93 (10) :693-699
[7]   Minimum Target Prices for Production of Direct-Acting Antivirals and Associated Diagnostics to Combat Hepatitis C Virus [J].
van de Ven, Nikolien ;
Fortunak, Joe ;
Simmons, Bryony ;
Ford, Nathan ;
Cooke, Graham S. ;
Khoo, Saye ;
Hill, Andrew .
HEPATOLOGY, 2015, 61 (04) :1174-1182
[8]  
WHO, 2015, WHO TECH REP SER, V994, P1
[9]  
WHO, 2002, WHO TECHN REP SER, V914, P14
[10]  
WHO, 2015, 19 WHO MOD LIST ESS